I D
× COMMENTARYCOVER STORYIN THE NEWSCHEMENTATOR + Show More BUSINESS NEWSTECHNICAL & PRACTICALFEATURE REPORTFACTS AT YOUR FINGERTIPSTECHNOLOGY PROFILESOLIDS PROCESSINGENGINEERING PRACTICEENVIRONMENTAL MANAGEREQUIPMENT & SERVICESFOCUS
Focus on Valves
    A new motorized control valve for the semiconductor…
NEW PRODUCTS + Show More

Comment Business & Economics

Wound dressing

By Chemical Engineering |

Last Month, Bayer Innovation GmbH (Leverkusen, Germany; edlinks.chemengonline.com/6896-551) started a pilot plant for producing a bioresorbable wound dressing in sufficient quantities to enable clinical trials to be carried out. Once the clinical phase of development is sucessfully completed, regulatory approval in the first market is expected in 2010. The dressing is based on silica gel fibers, which form a scaffold around which skin cells can grow, and is then decomposed by the body during the wound-healing process. The basic technology was first discovered ten years ago by the Fraunhofer Institute for Silicate Research (Würzburg), and subsequently developed by Bayer Innovation.
Related Content

Chemical Engineering publishes FREE eletters that bring our original content to our readers in an easily accessible email format about once a week.
Subscribe Now
Metering gas in biogas plants
Wet process analyzer for FPD and solar cell manufacturing for semi-conductors
Fluidized bed drying and cooling for temperature-sensitive polymers and plastics
CoriolisMaster: The SmartSensor solution
The Big 6 flowmeter technologies: Where to use them and why

View More